 MIAMI, Oct. 05, 2022 GLOBE NEWSWIRE -- Longeveron Inc. NASDAQ: LGVN Longeveron or Company, a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that Chris Min, M.D., Ph.D., Interim Chief Executive Officer, and Chief Medical Officer at Longeveron, will present at the upcoming Dawson James Small Cap Growth Conference taking place in Jupiter, Florida from October 11-12, 2022. 